Jiro Nagatomi

1.8k citations
43 papers · 1.4k indexed · h-index 22
Topics
Tissue Engineering and Regenerative Medicine (16 papers)Urinary Bladder and Prostate Research (9 papers)Electrospun Nanofibers in Biomedical Applications (7 papers)

In The Last Decade

Jiro Nagatomi

43 papers receiving 1.3k citations

Peers

Jiro Nagatomi
Comparison fields: 5 of 112
  • Biomedical Engineering 493
  • Surgery 410
  • Urology 385
  • Molecular Biology 215
  • Biomaterials 198
Replace Y. Liu with:
Y. Liu United States
Inbo Han South Korea
Csaba Matta Hungary
Jun Zou China
P A Hulley United Kingdom
Masamitsu Oshima Japan
Amy L. McNulty United States
Chi Ma China
Madhu Dhar United States
Nuno A. Silva Portugal
Jiro Nagatomi relative to Y. Liu United States Y. Liu's profile →
Citations per field
00.5×3.0×
Y. Liu · 1×
Citations per year

Countries citing papers authored by Jiro Nagatomi

Since Specialization
Citations

This map shows the geographic impact of Jiro Nagatomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Nagatomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Nagatomi more than expected).

Fields of papers citing papers by Jiro Nagatomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Nagatomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Nagatomi. The network helps show where Jiro Nagatomi may publish in the future.

Co-authorship network of co-authors of Jiro Nagatomi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Nagatomi. A scholar is included among the top collaborators of Jiro Nagatomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Nagatomi. Jiro Nagatomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 2
4 6
5 12
6 57
7 54
8 67
9 223
10 24
11 40
12 24
13 21
14 30
15 33
16 14
17 47
18 21
19 76
20 38

About Jiro Nagatomi

Jiro Nagatomi is a scholar working on Urology, Biomaterials and Clinical Biochemistry, having authored 43 papers that have together received 1.4k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (16 papers), Urinary Bladder and Prostate Research (9 papers) and Electrospun Nanofibers in Biomedical Applications (7 papers). The work is most often cited by research in Urology (385 citations), Sensory Systems (159 citations) and Biomaterials (198 citations). Jiro Nagatomi has collaborated with scholars based in United States, France and Finland. Frequent co-authors include Michael B. Chancellor, Michael S. Sacks, Rena Bizios, Utkan Demirci, Sangjun Moon, Feng Xu, Young Seok Song, Bernard P. Arulanandam, Alain Meunier and Dennis W. Metzger. Their work appears in journals such as PLoS ONE, Biomaterials and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026